What Will Happen To Coverage Of Covid-19 Tests, Vaccines, And Treatments Once The Government Is No Longer The Predominant Purchaser?

In August, the Biden Administration announced it will stop being the predominant purchaser of Covid-19 vaccines, treatments, and tests at some point this autumn, as it moves “beyond the crisis phase of the pandemic.” White House Covid-19 Response Team coordinator Dr. Ashish Jha said his “hope is that in 2023, you're going to see the commercialization of almost all of these products.”

One product that will not be impacted by this change in procurement policy is the updated Omicron BA.5-specific vaccine. The Biden Administration has signed purchase agreements for these vaccine doses....